LZM009 to Treat Patients With Advanced Solid Tumors
Clinical trial NCT03286296 · COMPLETED
Trial details
- NCT number
- NCT03286296
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2019-03-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.